| MolName | 4-[(5Z)-5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-[5-[(2-chlorophenyl)methyl]-1,3-thiazol-2-yl]butanamide |
| MolecularFormula | C24H20N3O2ClS3 |
| Smiles | O=C(CCCN(C(/C(/S1)=C/c2ccccc2)=O)C1=S)Nc1ncc(Cc(cccc2)c2Cl)s1 |
| InChI | InChI=1S/C24H20ClN3O2S3/c25-19-10-5-4-9-17(19)14-18-15-26-23(32-18)27-21(29)11-6-12-28-22(30)20(33-24(28)31)13-16-7-2-1-3-8-16/h1-5,7-10,13,15H,6,11-12,14H2,(H,26,27,29) |
| InChIK | BPGVDIKPMUOXNF-UHFFFAOYSA-N |
| TotalMolweight | 514.093 |
| Molweight | 514.093 |
| MonoisotopicMass | 513.040614 |
| CLogP | 5.2277 |
| CLogS | -7.242 |
| H Acceptors | 5 |
| H Donors | 1 |
| TotalSurfaceArea | 376.61 |
| Relative PSA | 0.31308 |
| PolarSurfaceArea | 147.93 |
| Druglikeness | 4.3233 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | limit! thiazol-2-ylamine |
| Shape Index | 0.63636 |
| Fragments | 1 |
| Non HAtoms | 33 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 8 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 6 |
| Symmetricatoms | 2 |
| Amides | 2 |
| Aromatic Nitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 4-[(5Z)-5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-[5-[(2-chlorophenyl)methyl]-1,3-thiazol-2-yl]butanamide | 2 - 4-[(5Z)-5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-[5-[(2-chlorophenyl)methyl]-1,3-thiazol-2-yl]butanamide